Is a strategy of intended incomplete percutaneous transluminal coronary angioplasty revascularization acceptable in nondiabetic patients who are candidates for coronary artery bypass graft surgery? The Bypass Angioplasty Revascularization Investigation (BARI)

Martial G. Bourassa, Kevin E. Kip, Alice K. Jacobs, Robert H. Jones, George Sopko, Allan D. Rosen, Barry L. Sharaf, Leonard Schwartz, Bernard R. Chaitman, Edwin L. Alderman, David Holmes, Gary S. Roubin, Katherine M. Detre, Robert L. Frye

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

OBJECTIVES: Our objective was to determine whether a strategy of intended incomplete percutaneous transluminal coronary angioplasty revascularization (IR) compromises long-term patient outcome. BACKGROUND: Complete angioplasty revascularization (CR) is often not planned nor attempted in patients with multivessel coronary disease, and the extent to which this influences outcome is unclear. METHODS: Before randomization, in the Bypass Angioplasty Revascularization Investigation, all angiograms were assessed for intended CR or IR via angioplasty. Outcomes were compared among patients with IR intended if assigned to angioplasty, randomized to coronary artery bypass graft surgery (CABG) versus angioplasty; and within angioplasty patients only, among patients with IR versus CR intended. RESULTS: At 5 years, there was a trend for higher overall (88.6% vs. 84.0%) and cardiac survival (94.5% vs. 92.1%) in CABG versus angioplasty patients with IR intended. The excess mortality in angioplasty patients occurred solely in diabetic subjects; overall and cardiac survival were similar among nondiabetic CABG and angioplasty patients, Freedom from myocardial infarction (MI) at 5 years was higher in nondiabetic CABG versus angioplasty patients (92.4% vs. 85.2%, p = 0.02), yet was similar to the rate observed (85%) in nondiabetic CABG and angioplasty patients with CR intended. Five-year rates of death, cardiac death, repeat revascularization and angina were similar in all angioplasty patients with IR versus CR intended. However, a trend for greater freedom from subsequent CABG was seen in CR patients (70.3% vs. 64.0%, p = 0.08). CONCLUSIONS: Intended incomplete angioplasty revascularization in nondiabetic patients with multivessel disease who are candidates for both angioplasty and CABG does not compromise long-term survival; however, subsequent need for CABG may be increased with this strategy. Whether the risk of long-term MI is also increased remains uncertain.

Original languageEnglish (US)
Pages (from-to)1627-1636
Number of pages10
JournalJournal of the American College of Cardiology
Volume33
Issue number6
DOIs
StatePublished - Jan 1 1999

Fingerprint

Coronary Balloon Angioplasty
Angioplasty
Coronary Artery Bypass
Transplants
Survival
Myocardial Infarction
Mortality

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Is a strategy of intended incomplete percutaneous transluminal coronary angioplasty revascularization acceptable in nondiabetic patients who are candidates for coronary artery bypass graft surgery? The Bypass Angioplasty Revascularization Investigation (BARI). / Bourassa, Martial G.; Kip, Kevin E.; Jacobs, Alice K.; Jones, Robert H.; Sopko, George; Rosen, Allan D.; Sharaf, Barry L.; Schwartz, Leonard; Chaitman, Bernard R.; Alderman, Edwin L.; Holmes, David; Roubin, Gary S.; Detre, Katherine M.; Frye, Robert L.

In: Journal of the American College of Cardiology, Vol. 33, No. 6, 01.01.1999, p. 1627-1636.

Research output: Contribution to journalArticle

Bourassa, Martial G. ; Kip, Kevin E. ; Jacobs, Alice K. ; Jones, Robert H. ; Sopko, George ; Rosen, Allan D. ; Sharaf, Barry L. ; Schwartz, Leonard ; Chaitman, Bernard R. ; Alderman, Edwin L. ; Holmes, David ; Roubin, Gary S. ; Detre, Katherine M. ; Frye, Robert L. / Is a strategy of intended incomplete percutaneous transluminal coronary angioplasty revascularization acceptable in nondiabetic patients who are candidates for coronary artery bypass graft surgery? The Bypass Angioplasty Revascularization Investigation (BARI). In: Journal of the American College of Cardiology. 1999 ; Vol. 33, No. 6. pp. 1627-1636.
@article{b4f9b931896049eabafc05184c12f934,
title = "Is a strategy of intended incomplete percutaneous transluminal coronary angioplasty revascularization acceptable in nondiabetic patients who are candidates for coronary artery bypass graft surgery? The Bypass Angioplasty Revascularization Investigation (BARI)",
abstract = "OBJECTIVES: Our objective was to determine whether a strategy of intended incomplete percutaneous transluminal coronary angioplasty revascularization (IR) compromises long-term patient outcome. BACKGROUND: Complete angioplasty revascularization (CR) is often not planned nor attempted in patients with multivessel coronary disease, and the extent to which this influences outcome is unclear. METHODS: Before randomization, in the Bypass Angioplasty Revascularization Investigation, all angiograms were assessed for intended CR or IR via angioplasty. Outcomes were compared among patients with IR intended if assigned to angioplasty, randomized to coronary artery bypass graft surgery (CABG) versus angioplasty; and within angioplasty patients only, among patients with IR versus CR intended. RESULTS: At 5 years, there was a trend for higher overall (88.6{\%} vs. 84.0{\%}) and cardiac survival (94.5{\%} vs. 92.1{\%}) in CABG versus angioplasty patients with IR intended. The excess mortality in angioplasty patients occurred solely in diabetic subjects; overall and cardiac survival were similar among nondiabetic CABG and angioplasty patients, Freedom from myocardial infarction (MI) at 5 years was higher in nondiabetic CABG versus angioplasty patients (92.4{\%} vs. 85.2{\%}, p = 0.02), yet was similar to the rate observed (85{\%}) in nondiabetic CABG and angioplasty patients with CR intended. Five-year rates of death, cardiac death, repeat revascularization and angina were similar in all angioplasty patients with IR versus CR intended. However, a trend for greater freedom from subsequent CABG was seen in CR patients (70.3{\%} vs. 64.0{\%}, p = 0.08). CONCLUSIONS: Intended incomplete angioplasty revascularization in nondiabetic patients with multivessel disease who are candidates for both angioplasty and CABG does not compromise long-term survival; however, subsequent need for CABG may be increased with this strategy. Whether the risk of long-term MI is also increased remains uncertain.",
author = "Bourassa, {Martial G.} and Kip, {Kevin E.} and Jacobs, {Alice K.} and Jones, {Robert H.} and George Sopko and Rosen, {Allan D.} and Sharaf, {Barry L.} and Leonard Schwartz and Chaitman, {Bernard R.} and Alderman, {Edwin L.} and David Holmes and Roubin, {Gary S.} and Detre, {Katherine M.} and Frye, {Robert L.}",
year = "1999",
month = "1",
day = "1",
doi = "10.1016/S0735-1097(99)00077-7",
language = "English (US)",
volume = "33",
pages = "1627--1636",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "6",

}

TY - JOUR

T1 - Is a strategy of intended incomplete percutaneous transluminal coronary angioplasty revascularization acceptable in nondiabetic patients who are candidates for coronary artery bypass graft surgery? The Bypass Angioplasty Revascularization Investigation (BARI)

AU - Bourassa, Martial G.

AU - Kip, Kevin E.

AU - Jacobs, Alice K.

AU - Jones, Robert H.

AU - Sopko, George

AU - Rosen, Allan D.

AU - Sharaf, Barry L.

AU - Schwartz, Leonard

AU - Chaitman, Bernard R.

AU - Alderman, Edwin L.

AU - Holmes, David

AU - Roubin, Gary S.

AU - Detre, Katherine M.

AU - Frye, Robert L.

PY - 1999/1/1

Y1 - 1999/1/1

N2 - OBJECTIVES: Our objective was to determine whether a strategy of intended incomplete percutaneous transluminal coronary angioplasty revascularization (IR) compromises long-term patient outcome. BACKGROUND: Complete angioplasty revascularization (CR) is often not planned nor attempted in patients with multivessel coronary disease, and the extent to which this influences outcome is unclear. METHODS: Before randomization, in the Bypass Angioplasty Revascularization Investigation, all angiograms were assessed for intended CR or IR via angioplasty. Outcomes were compared among patients with IR intended if assigned to angioplasty, randomized to coronary artery bypass graft surgery (CABG) versus angioplasty; and within angioplasty patients only, among patients with IR versus CR intended. RESULTS: At 5 years, there was a trend for higher overall (88.6% vs. 84.0%) and cardiac survival (94.5% vs. 92.1%) in CABG versus angioplasty patients with IR intended. The excess mortality in angioplasty patients occurred solely in diabetic subjects; overall and cardiac survival were similar among nondiabetic CABG and angioplasty patients, Freedom from myocardial infarction (MI) at 5 years was higher in nondiabetic CABG versus angioplasty patients (92.4% vs. 85.2%, p = 0.02), yet was similar to the rate observed (85%) in nondiabetic CABG and angioplasty patients with CR intended. Five-year rates of death, cardiac death, repeat revascularization and angina were similar in all angioplasty patients with IR versus CR intended. However, a trend for greater freedom from subsequent CABG was seen in CR patients (70.3% vs. 64.0%, p = 0.08). CONCLUSIONS: Intended incomplete angioplasty revascularization in nondiabetic patients with multivessel disease who are candidates for both angioplasty and CABG does not compromise long-term survival; however, subsequent need for CABG may be increased with this strategy. Whether the risk of long-term MI is also increased remains uncertain.

AB - OBJECTIVES: Our objective was to determine whether a strategy of intended incomplete percutaneous transluminal coronary angioplasty revascularization (IR) compromises long-term patient outcome. BACKGROUND: Complete angioplasty revascularization (CR) is often not planned nor attempted in patients with multivessel coronary disease, and the extent to which this influences outcome is unclear. METHODS: Before randomization, in the Bypass Angioplasty Revascularization Investigation, all angiograms were assessed for intended CR or IR via angioplasty. Outcomes were compared among patients with IR intended if assigned to angioplasty, randomized to coronary artery bypass graft surgery (CABG) versus angioplasty; and within angioplasty patients only, among patients with IR versus CR intended. RESULTS: At 5 years, there was a trend for higher overall (88.6% vs. 84.0%) and cardiac survival (94.5% vs. 92.1%) in CABG versus angioplasty patients with IR intended. The excess mortality in angioplasty patients occurred solely in diabetic subjects; overall and cardiac survival were similar among nondiabetic CABG and angioplasty patients, Freedom from myocardial infarction (MI) at 5 years was higher in nondiabetic CABG versus angioplasty patients (92.4% vs. 85.2%, p = 0.02), yet was similar to the rate observed (85%) in nondiabetic CABG and angioplasty patients with CR intended. Five-year rates of death, cardiac death, repeat revascularization and angina were similar in all angioplasty patients with IR versus CR intended. However, a trend for greater freedom from subsequent CABG was seen in CR patients (70.3% vs. 64.0%, p = 0.08). CONCLUSIONS: Intended incomplete angioplasty revascularization in nondiabetic patients with multivessel disease who are candidates for both angioplasty and CABG does not compromise long-term survival; however, subsequent need for CABG may be increased with this strategy. Whether the risk of long-term MI is also increased remains uncertain.

UR - http://www.scopus.com/inward/record.url?scp=0033133529&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033133529&partnerID=8YFLogxK

U2 - 10.1016/S0735-1097(99)00077-7

DO - 10.1016/S0735-1097(99)00077-7

M3 - Article

C2 - 10334434

AN - SCOPUS:0033133529

VL - 33

SP - 1627

EP - 1636

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 6

ER -